Anaphylaxis to oral misoprostol in a term pregnant patient who is non-allergic to vaginal misoprostol-a case report

Vineeth V. K.; Maria Jose

doi:10.18203/2319-2003.ijbcp20232576

Authors

Vineeth V. K. Nyle Hospital, Kaiparambu, Thrissur, Kerala, India
Maria Jose Department of Pharmacology, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20232576

Keywords:

Anaphylaxis, Misoprostol, Case report, Hypersensitivity, Term pregnancy

Abstract

Misoprostol (PGE1) is a drug that is very commonly used in obstetrics for labour induction. Apart from its side effect of causing congenital malformations in offspring of users who have unsuccessfully used it as an abortifacient, it is considered a safe drug with few side effects. We here report a severe hypersensitivity reaction to misoprostol in a 33-year-old term pregnant patient who is non-allergic to vaginal misoprostol. The patient developed anaphylactic features like swelling of lips, low voice due to laryngeal oedema, and bradycardia. Prompt administration of adrenaline and emergent caesarean section allowed for the safe delivery of the neonate. When inducing labour, quick identification and treatment of anaphylaxis and hypersensitivity reactions are necessary to prevent maternal and neonatal morbidity and mortality.

Metrics

Metrics Loading ...

References

Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2012;130:597.

Fiala C, Gemzell-Danielsson K. Review of Medical Abortion Using Mifepristone in Combination with Prostaglandin Analogue. Contraception. 2006;74(1):66-86.

Tang J, Kapp N, Dragoman M, De Souza JP. WHO Recommendations for Misoprostol Use for Obstetric and Gynecologic Indications. Int J Gynecol Obstetr. 2013;121:186-9.

Schoen C, Campbell S, Maratas A, Kim C. Anaphylaxis to buccal misoprostol for labor induction. Obstet Gynecol. 2014;124:466.

Soter NA, Austen KF. Urticaria/angioedema. The mast cell, its diverse mediators, and its role in cutaneous in¬flammation. In: Safai B, Good RA, editors. Immunoder¬matology. Comprehensive immunology vol 7, New York (NY): Springer. 1981;273-92.

Madaan M, Puri M, Sharma R, Trivedi SS. Hypersensitiv¬ity reaction to misoprostol-a case report. Int J Clin Med. 2012;3:223-4.

Meuleman C, Jourdain P, Bellorini M, Guillard N, Loi-ret J, Thebault B et al. Anaphylactic Shock and Myocytic Necrosis after Treatment with Artotec. Archives des Maladies du Coeur et des Vaisseaux. 2002;95(12):1230-33.

Shin HJ, Lee SR, Roh AM, Lim YM, Jeong KA, Moon HS et al. Anaphylactic shock to vaginal misoprostol: a rare adverse reaction to a frequently used drug. Obstet Gynecol Sci. 2018;61(5):636-40.

Babakhin AA, Nolte H, DuBuske LM. Effect of Misoprostol on the Secretion of Histamine from Basophils of Whole Blood. Ann Allergy Asthma Immunol. 2000;84(3):361-5.

Marfatia YS, Patel D, Menon DS, Naswa S. Genital contact allergy: A diagnosis missed. Indian J Sex Transm Dis AIDS. 2016;37(1):1-6.

Drug Review. Misoprostol an old drug, new indications. Br J Postgrad Med. 2002;48(4):336-9.

Rehan-Uddin K, El-Refaey H, Sunita S, Sooranna D, Stafford M. Oral, Rectal, and Vaginal Pharmacokinetics of Misoprostol. Obstetr Gynecol. 2004;103(5 Part 1):866-70.

Philp JR. Allergic Drug Reactions. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths. 1990;214.